Literature DB >> 27918085

PPARα Promotes Cancer Cell Glut1 Transcription Repression.

Mengli You1,2, Jianhua Jin1, Qian Liu1, QingGang Xu2, Juanjuan Shi2, Yongzhong Hou1,2.   

Abstract

Abundant nutrient availability including glucose and amino acids plays an important role in maintaining cancer cell energetic and biosynthetic pathways. As a nuclear receptor, peroxisome-proliferator-activated receptor α (PPARα) regulates inflammation and cancer progression, however, it is still unclear the interaction of PPARα with the cancer cell glucose metabolism. Here we found that PPARα reduced Glut1 (Glucose transporter 1) protein and gene levels in HCT-116, SW480, HeLa, and MCF-7 cancer cell lines. In contrast, silenced PPARα reversed this event. Further analysis shows that PPARα directly targeted the consensus PPRE motif of Glut1 promoter region resulting in Glut1 transcription repression. PPARα-mediated Glut1 transcription repression led to decreased influx of glucose in cancer cells. These findings revealed a novel mechanism of PPARα-mediated cancer cell Glut1 transcription repression. J. Cell. Biochem. 118: 1556-1562, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  CELL SIGNALING; GLUT1; PPARα; TRANSCRIPTION REPRESSION

Mesh:

Substances:

Year:  2017        PMID: 27918085     DOI: 10.1002/jcb.25817

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  10 in total

1.  Metabolic role of fatty acid binding protein 7 in mediating triple-negative breast cancer cell death via PPAR-α signaling.

Authors:  Soke Chee Kwong; Amira Hajirah Abd Jamil; Anthony Rhodes; Nur Aishah Taib; Ivy Chung
Journal:  J Lipid Res       Date:  2019-09-04       Impact factor: 5.922

2.  PPARδ is a regulator of autophagy by its phosphorylation.

Authors:  Qian Gou; Yidan Jiang; Runyun Zhang; Ying Xu; Huihui Xu; Wenbo Zhang; Juanjuan Shi; Yongzhong Hou
Journal:  Oncogene       Date:  2020-05-21       Impact factor: 9.867

Review 3.  Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer.

Authors:  Nicole Wagner; Kay-Dietrich Wagner
Journal:  Cells       Date:  2022-08-05       Impact factor: 7.666

4.  Hippocampal PPARα is a novel therapeutic target for depression and mediates the antidepressant actions of fluoxetine in mice.

Authors:  Lu Song; Hao Wang; Ying-Jie Wang; Jin-Liang Wang; Qing Zhu; Feng Wu; Wei Zhang; Bo Jiang
Journal:  Br J Pharmacol       Date:  2018-06-03       Impact factor: 8.739

Review 5.  Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy.

Authors:  Qian Gou; Xin Gong; Jianhua Jin; Juanjuan Shi; Yongzhong Hou
Journal:  Oncotarget       Date:  2017-07-27

6.  PPARα Enhances Cancer Cell Chemotherapy Sensitivity by Autophagy Induction.

Authors:  Mengli You; Jiaming Gao; Jianhua Jin; Yongzhong Hou
Journal:  J Oncol       Date:  2018-11-04       Impact factor: 4.375

7.  ACOX2 is a prognostic marker and impedes the progression of hepatocellular carcinoma via PPARα pathway.

Authors:  Qifan Zhang; Yunbin Zhang; Shibo Sun; Kai Wang; Jianping Qian; Zhonglin Cui; Tao Tao; Jie Zhou
Journal:  Cell Death Dis       Date:  2021-01-04       Impact factor: 8.469

Review 8.  Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells.

Authors:  Valdenizia R Silva; Luciano de S Santos; Rosane B Dias; Claudio A Quadros; Daniel P Bezerra
Journal:  Cancer Commun (Lond)       Date:  2021-11-17

Review 9.  Signaling pathways in the regulation of cancer stem cells and associated targeted therapy.

Authors:  Wang Manni; Wu Min
Journal:  MedComm (2020)       Date:  2022-10-05

Review 10.  The Involvement of PPARs in the Peculiar Energetic Metabolism of Tumor Cells.

Authors:  Andrea Antonosante; Michele d'Angelo; Vanessa Castelli; Mariano Catanesi; Dalila Iannotta; Antonio Giordano; Rodolfo Ippoliti; Elisabetta Benedetti; Annamaria Cimini
Journal:  Int J Mol Sci       Date:  2018-06-29       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.